Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.
Sgherza N, Zucano S, Vitucci A, Palma A, Tarantini F, Campanale D, Vimercati L, Larocca AMV, Visceglie D, Acquafredda A, Ostuni A, Di Gennaro D, Vitucci C, Tafuri S, Musto P.
Sgherza N, et al. Among authors: palma a.
Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022056. doi: 10.4084/MJHID.2022.056. eCollection 2022.
Mediterr J Hematol Infect Dis. 2022.
PMID: 35865398
Free PMC article.
No abstract available.